ASCENDIS PHARMA A/S - NOTE 2.250% 4/0

Historical Holders from Q2 2023 to Q4 2025

Type / Class
Debt / NOTE 2.250% 4/0
Market price (% of par)
141.67%
All holders as of 30 Sep 2025
Q3 2025
Total 13F principal
$483,214,000
Total reported market value
$683,676,184
Principal change
-$1,388,000
Market value change
-$186,644
Number of holders
41
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
44 filings reported holding 04351PAD3 - ASCENDIS PHARMA A/S - NOTE 2.250% 4/0.
ASCENDIS PHARMA A/S - NOTE 2.250% 4/0 has 41 institutional bondholders. These institutions hold $483,214,000 principal (par value) of the bond.

Institutional Holders of ASCENDIS PHARMA A/S - NOTE 2.250% 4/0 across Reporting Periods

Period Principal Value Change Price (% of par) Investors
2025 Q4 $1,158,000 $26,682,439 +$161,504 141.67% 3
2025 Q3 $483,214,000 $683,676,184 -$186,644 136.38% 41
2025 Q2 $526,422,000 $659,791,143 -$19,673,568 125.31% 41
2025 Q1 $534,013,999 $655,394,730 -$1,900,121 118.55% 40
2024 Q4 $556,318,000 $612,674,297 -$16,374,567 110.04% 41
2024 Q3 $566,020,430 $656,636,350 -$1,520,196 116.54% 42
2024 Q2 $569,471,000 $635,090,756 +$11,704,865 111.5% 37
2024 Q1 $552,283,575 $644,558,035 -$19,758,059,780 115.55% 37
2023 Q4 $571,154,000 $586,959,623 +$12,691,698 102.78% 34
2023 Q3 $562,476,075 $517,038,664 -$2,688,912 91.88% 34
2023 Q2 $565,722,400 $515,987,274 +$515,987,274 91.25% 35